Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Salona Global Medical Device CorpLNDZF · Entity 137446 | Director | June 09, 2021 | June 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Salona Global Medical Device Corp
Report date June 09, 2021 · Filed June 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,048,056 |
Ending reported balance
After 2021-06-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-06-09 · Purchase · Acquired 50,000 · Balance 1,023,056 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.54. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Row 2 · 2021-06-10 · Purchase · Acquired 25,000 · Balance 1,048,056 F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.61 to $0.63. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.54. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.61 to $0.63. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Alphatec Holdings, Inc.
Report date April 25, 2017 · Filed June 26, 2017
Section 16 reporting ended · disclosed 2017-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 84,382 |
Reported balance
After 2017-04-25 transaction · row 1
1 source rowRow 1 · 2017-04-25 · Grant · Acquired 18,939 · Balance 84,382 F1: The shares vest in four equal annual installments beginning on the first anniversary of the grant date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.98 · Expires 2027-04-25 | Direct | 28,090 |
Reported balance
After 2017-04-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-25 · Grant · Acquired 28,090 · Balance 28,090 F2: The option vests 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares vest in four equal annual installments beginning on the first anniversary of the grant date.
F2: The option vests 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2021 Filed Jun 11, 2021 16:18 UTC | Salona Global Medical Device Corp LNDZF · Entity 137446 | PurchaseCommon Stock | 25,000 | $0.62 | $15,500.00 |
DisclosureSEC source: 0001104659-21-080141 · tm2119523-1_4seq1.xml · nonDerivative · entry 2 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048,056 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.61 to $0.63. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 16:18 UTC | Salona Global Medical Device Corp LNDZF · Entity 137446 | PurchaseCommon Stock | 50,000 | $0.50 | $25,000.00 |
DisclosureSEC source: 0001104659-21-080141 · tm2119523-1_4seq1.xml · nonDerivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023,056 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.44 to $0.54. The Reporting Person undertakes to provide to Salona Global Medical Device Corp., any security holder of Salona Global Medical Device Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| April 25, 2017 Filed Jun 26, 2017 19:07 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantStock Option (right to buy) · Derivative | 28,090 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001179110-17-009626 · edgar.xml · derivative · entry 2 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,090 Underlying: Common Stock · 28,090 shares Expires 2027-04-25 F2 · derivative.exercise_date: The option vests 25% on the first anniversary of the grant date and thereafter in 36 equal monthly installments. Read SEC document |
| April 25, 2017 Filed Jun 26, 2017 19:07 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 18,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-009626 · edgar.xml · nonDerivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,382 F1 · shares: The shares vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 21, 2017 Filed May 3, 2017 14:02 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantNQ Stock Option · Derivative | 5,208 | $3.09 Strike: $3.09 | $16,092.72 |
DisclosureSEC source: 0001179110-17-006461 · edgar.xml · derivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,208 Underlying: Common Stock · 5,208 shares Expires 2027-02-21 F1 · derivative.exercise_date: The options will vest 25% on the first anniversary of the grant date and 1/12th of the shares vest every 3 months thereafter. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 20:24 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | PurchaseCommon Sock | 15,000 | $4.25 | $63,795.00 |
DisclosureSEC source: 0001350653-16-000129 · wf-form4_148228347487897.xml · nonDerivative · entry 1 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,443 Read SEC document |
| December 12, 2016 Filed Dec 16, 2016 13:15 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantNQ Stock Option · Derivative | 7,751 | $4.43 Strike: $4.43 | $34,336.93 |
DisclosureSEC source: 0001350653-16-000120 · wf-form4_148191211310081.xml · derivative · entry 2 CROSS LESLIE H · CIK 0001248189 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,794 Underlying: Common Stock · 7,751 shares Expires 2026-12-12 F2 · shares: The options are fully vested as of the grant date. F3 · price: The exercise price per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.